Introduction
Ischaemia/reperfusion (I/R) injury is a severe clinical condition that often results from cardiac surgeries or therapy for ST segment elevation myocardial infarction (STEMI), such as thrombolytic therapy and percutaneous coronary intervention. Rapid reperfusion is the most effective strategy in limiting infarct size (IS), but such an injury can also lead to cell dysfunction and death, and ultimately contribute to tissue damage. 1 Remote ischaemic preconditioning (RIPC), induced by several episodes of brief ischaemia and reperfusion at a distance, confers systemic multiorgan protection against I/R injury. 2 The protective effects of RIPC has two phases, with the first occurring immediately after preconditioning (PC) and the other appearing 24 h after PC, termed late RIPC. 3 Recent studies report that as a non-invasive RIPC stimulus via transient limb ischaemia, induced by inflating a blood pressure cuff placed on the upper or lower limb, reduces myocardial I/R injury in many clinical situations, including coronary artery surgery and congenital heart surgery in highrisk patients or patients with STEMI, regardless of whether the patient is undergoing primary percutaneous coronary intervention or thrombolysis. 4 The potential mechanisms and signal transduction pathways underlying RIPC have been proposed and depicted in the studies discussed thus far. The remote organ or tissue stimulated by PC generates endogenous substances, such as glycine, 5 kynurenine adenosine, 6 ornithine, spermine, carnosine, serotonin, 7 apolipoprotein a, 8 calcitonin generelated peptide, opioids, endocannabinoids, Angiotensin I, nitric oxide, stromal-derived factor-1a, microRNA-144, 9 ,10 and other not-yet identified factors that transfer to the heart through neuronal and hormonal communications. These factors activate their respective receptors in the myocardium, thereby triggering intracellular signal transduction, and ultimately contribute to RIPC-induced cardioprotection. However, the true mechanisms of RIPC have not yet been identified. Stat5, a member of signal transducers and activators of transcription (Stat), plays a key role in this process. The STAT5 protein can be phosphorylated by activating Janus kinase (JAK), and translocated into the nucleus with a form of homo-or heterodimerization, where it binds to the promoter region of, and regulates the transcription of, the target genes. 11, 12 In addition, STAT5 has been reported to regulate the expression of genes encoding proteins involved in cell proliferation, differentiation, angiogenesis, inflammation, apoptosis, extracellular matrix composition, and cellular signalling. 11, 13, 14 Heusch et al., 15 induced RIPC using three cycles of arm I/R in patients undergoing elective coronary bypass surgery and obtained myocardial biopsies during reperfusion to analyse an array of established cardioprotective proteins. The results showed that phosphorylation of STAT5 was greater in the patients with RIPC than in the control patients, indicating that STAT5 may play a critical role in the process of PC. Nevertheless, the role of STAT5 in RIPC has not been studied thoroughly. To explore this and the underlying mechanisms for STAT5-activation involved in RIPC, we tested the hypothesis that RIPC-induced late cardioprotection requires STAT5 to be effective. Thus, we employed Stat5 knockout (Stat5-cKO) mice and generated I/R models with or without RIPC.
Methods

Antibodies and reagents
Antibodies for p-STAT5 (Try694), STAT5, p-STAT3 (Try705), STAT3, p-PI3K (Try 458), PI3K, p-AKT (Ser473), AKT, Cytochrome c (Cyt c), Caspase-3, cleaved Caspase-3, B-cell lymphoma-extra large (Bcl-xL), B-cell lymphoma-2 (Bcl-2), and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were obtained from Cell Signaling. Antibodies for VEGF, HIF-1a, IL10, and b-actin were purchased from Abcam (Cambridge, UK). The in situ cell-death detection kit to assess apoptosis, peroxidase (POD) (TUNEL), was purchased from Roche (Lewes, UK). The triphenyltetrazolium chloride (TTC) was purchased from SigmaAldrich (St. Louis, MO, USA). 
Cre mice. When the mice reached 7 weeks of age, the Doxycycline hyclate (Dox) (Sigma-Aldrich, St Louis, MO) treatment was carried out in the drinking water at a concentration of 2 mg/ml for 7 days. 16 Genotyping was performed by polymerase chain reaction (PCR) using genomic DNA and the following primers: (i) 5'-agcagcaaccagaggactac-3'; (ii) 5'-cccattatcaccttctttacag-3'; and (iii) 5'-tacccgcttccattgctcag-3'. To check for deletion efficiency, primers (i) and (ii) were used to detect the Stat5a/b-null alleles (590 bp), and a and c were used for the floxed allele (530 bp).
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Study groups
The experimental procedures are shown in Figure 1 . Two types of mice were used in this study: 
In vivo experiments
The mice were anaesthetized with intraperitoneal (IP) injection of pentobarbital (70 mg/kg). The left femoral artery was exposed at the inguinal ligament and separated from the femoral vein and nerve. A microvascular clip was used to occlude the artery for 5 min, followed by release of the clip and reperfusion for 5 min, repeated for a total of three cycles. Sham surgery was identical except that the artery was not occluded. 17 Twenty-four hours later, some of the mice (Stat5 þRIPC, Stat5-cKO, Stat5-cKO þ RIPC) were euthanized using CO 2 inhalation and cervical dislocation. Death was confirmed by ascertaining cardiac and respiratory arrest. Heart tissues were removed to detect protein levels of IL10, PI3K, and AKT without undergoing I/R surgery. Other mice (Stat5 electrocardiographic abnormalities (ST segment elevation and QRS complex widening). After 30 min, the slipknot was loosened to recover perfusion for 180 min. 19 At the end of the experiment, animals were sacrificed and their blood samples were measured for levels of serum lactate dehydrogenase (LDH), creatine kinase (CK), and creatine kinase-MB (CK-MB). The hearts were removed for assessment of IS, myocardial cell apoptosis, and protein levels of p-STAT5, p-STAT3, VEGF, HIF-1a, Bcl-xL, Bcl-2, Cyt c, and Caspase-3.
Myocardial enzyme analysis and myocardial IS measurements
Following a 3-h reperfusion period, blood was collected and centrifuged (10 000 g for 10 min, at 4 C). Serum LDH, CK, and CK-MB levels were analysed with a biochemistry analyser at the Medical Laboratory of Jiangsu Province Hospital (Nanjing, China). At the end of reperfusion, the loop around the coronary artery was retightened and 2% Evans blue dye was injected from the apex into the left ventricle. The heart was excised, frozen, and cut transversely into five sections, then stained with 2% TTC for 10-15 min at 37
C. Both sides of each section were photographed and IS, area at risk (AAR), and total LV were determined and analysed by Image-Pro Plus 6.0 software.
Apoptosis measurements
The frozen sections of mouse hearts were fixed in 4% paraformaldehyde for 30 min, then permeabilized with 0.1% Triton X-100 in 0.1% sodium citrate for 10 min. Terminal deoxynucleotidyl transferase-mediated biotinylated UTP triphosphate nick-end labelling assay (TUNEL; In Situ Cell Death Detection FITC Kit or TMR red, Roche) was performed according to the instructions, and cryosections were blocked with 5% goat serum albumin in phosphate buffered saline (PBS) with Tween 20 for 1 h. Samples were incubated with anti-a-actinin antibody (1:800; SigmaAldrich; A7811) in a humidified chamber overnight at 4 C, followed by secondary antibody (red; Abcam; ab150115) incubation. DAPI was used to stain the nuclei for 5 min. Fluorescence microscope (Nikon, Japan) was used to detect TUNEL-positive cells (which were localized within non-infarcted risk areas) in randomly selected fields.
Western blotting
The cardiac tissues were ground in liquid nitrogen and lysed with RIPA buffer supplemented with a protease inhibitor cocktail and a Stat5-dependent cardioprotection in late remote ischaemia preconditioning phosphatase inhibitor cocktail. After detecting the concentrations through a BCA protein assay (Pierce), equivalent amounts of protein (30 mg/lane) were separated by SDS-polyacrylamide gel electrophoresis and transferred onto PVDF membranes. Nonspecific reactivity was blocked in 5% BSA in TBST (10 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% Tween-20) for 1 h. Each membrane was incubated with a primary antibody against VEGF (1:800), HIF-1a (1:1000), Bcl-xL (1:1000), Bcl-2 (1:1000), anti-Cyt c (1:1000), Caspase-3 (1:1000), cleaved Caspase-3 (1:1000), Phospho-STAT5 (1:1000), STAT5 (1:1000), Phospho-STAT3 (1:1000), STAT3 (1:1000), Phospho-PI3K (1:1000), PI3K (1:1000), Phospho-AKT (1:1000), AKT (1:1000), IL10 (1:1000), b-actin(1:1000), or GAPDH (1:1000) overnight at 4 C, then with a secondary antibody for 2 h at room temperature. Proteins were quantified using SuperSignal West Pico Chemiluminescent substrate (Pierce). In our study, we detected the total and phosphorylated protein in separate gels, and normalized the phosphorylated protein levels to their own loading control and then to the normalized total protein (phosphorylated protein/ GAPDH or b-actin)/(total protein/GAPDH or b-actin).
Statistics
All values are expressed as mean ± S.E.M. Statistical analysis was performed using software SPSS 18.0; two-group comparison (analysis of deletion efficiency at genomic level of STAT5) was determined using the unpaired two-tailed Student's t-test, and multiple-group comparisons were made by the one-or two-way analysis of variance (ANOVA) test, followed by the post hoc Bonferroni test. P < 0.05 was accepted as statistically significant. Exact values and sample sizes are provided in the Section 3, and individual statistical results for all analyses are provided in the figure legends.
Results
3.1 Cardiomyocyte-specific Stat5-cKO mice had a normal baseline cardiac performance without any abnormal phenotype
In this study, we detected a 65% reduction in Stat5 protein (P < 0.001) in whole heart tissues of the Stat5-cKO mice ( Figure 1C and D) . The sufficient deletion efficiency at genomic level was verified by PCR ( Figure 1B) . To assess the basic cardiac function of Stat5-cKO mice, echocardiography was performed after eight weeks. Results showed that all parameters of cardiac function had not changed in both Cre , and Stat5-cKO mice (Figure 2A-N To evaluate the protective effects of RIPC on ischaemia reperfusion (IR), we first measured myocardial infarction size and serum enzyme levels. The AAR was determined by Evans blue staining, and IS was distinguished by TTC staining ( Figure 3A) . RIPC significantly reduced IS in þI/R group; mean ± S.E.M.; P <0.01) ( Figure 3B ) or as a percentage of AAR (42.2 ± 3.5% compared with 69.2 ± 4.9%; P < 0.01) ( Figure 3C ). In contrast, there was no significant difference between the Stat5-cKO þ I/R and the Stat5-cKO þ RIPC þ I/R groups in terms of IS, whether analysed
; p > 0.05, and AAR, 66.6 ± 4.4 vs. 70.7 ± 5%; p > 0.05) ( Figure 3B and C). The levels of serum enzymes, such as CK, CK-MB, and LDH, which reflect acute myocardial injury, were measured from peripheral blood of the mice. When compared with the Stat5 fl/fl þI/R group, the concentrations of CK, CK-MB, and LDH were significantly lower in the Stat5 fl/fl þRIPC þ I/R group. However, there was no significant difference in enzyme levels between the Stat5-cKO þ I/R and Stat5-cKO þ RIPC þ I/R groups ( Figure 3E-G) .
TUNEL staining was performed to assess the occurrence of apoptosis in myocardial cells. The assay demonstrated that the number of TUNELpositive cells was reduced from 5.62 ± 0.97 to 2.42 ± 0.52% in the Stat5 fl/fl þRIPC þ I/R group compared to the Stat5 fl/fl þI/R group (P < 0.01). On the other hand, there was no significant difference between the Stat5-cKO þ RIPC þ I/R and the Stat5-cKO þ I/R groups (5.57 ± 1.1 vs. 5.83 ± 0.6%; P > 0.05) ( Figure 4A and B) .
Protein expression of p-STAT5 and p-STAT3 following I/R
To further explore the molecular mechanism of RIPC and its relationship with Stat5, we examined the protein levels of p-STAT5 in heart tissues through western blotting. p-STAT5/STAT5 indicated markedly increased phosphorylation of STAT5 in the Stat5 fl/fl mice with RIPC stimulates, compared with Stat5 fl/fl mice that were subjected to I/R only. In contrast, the RIPC had no effect on STAT5 activation in the hearts of Stat5-cKO mice, which is consistent with the loss of cardioprotection described above ( Figure 5A and B). The activation of STAT3 is also known to be involved in the reduction of myocardial injury through RIPC and is highly homogeneous with STAT5. 20, 21 Therefore, we assessed the protein levels of p-STAT3 in the heart tissues as well. Expression of p-STAT3 after I/R was significantly higher in Stat5-cKO hearts compared with the Stat5 fl/fl . However, following RIPC, expression of p-STAT3 was in trend of increase in the Stat5 fl/fl hearts but not in the Stat5-cKO hearts ( Figure 5C and D). In order to present different renderings of the protein data, we also measured the phosphorylated protein levels by using GAPDH or b-actin only as baseline (see Supplementary material online, Figure S1 ). P-STAT5/GAPDH in the Stat5-cKO hearts was not higher than that in the Stat5 fl/fl þ I/R hearts, in contrary to that when total STAT5 (after normalized by respective loading control) was used as the baseline. Additionally, different with p-STAT3/STAT3, p-STAT3/ b-actin in the Stat5-cKO þ RIPC hearts did not show a significant increase compared to the Stat5 fl/fl hearts.
3.4 Late RIPC promoted anti-apoptotic signaling and inhibited pro-apoptotic signaling in the heart of the Stat5 fl/fl mice but not in the Stat5-cKO mice Previous studies have demonstrated that apoptosis plays a fundamental biological role in myocardial I/R injury. 22 To further study whether Stat5
is involved in anti-apoptosis during the RIPC process, we detected the proteins participating in apoptotic and anti-apoptotic signaling in myocardial tissues, including Caspase-3, Cyt c, Bcl-2, and Bcl-xL. Western blot results showed that the expression of apoptotic proteins Cyt c and cleaved Caspase-3 were decreased in the Stat5 fl/fl þRIPC þ I/R group (P < 0.05), whereas anti-apoptotic molecules, including Bcl-2 and Bcl-xL, were significantly increased, compared with the Stat5 fl/fl þI/R group. This result suggests an anti-apoptotic mechanism involved in the cardioprotective effects of RIPC against I/R injury. In contrast, we did not detect significant differences in these protein expressions in the hearts of Stat5-cKO mice with or without RIPC, suggesting that Stat5 is required for regulating apoptotic signaling induced by the RIPC stimulus ( Figure 6A-F) .
Late RIPC promoted HIF-1a/VEGF and cardiomyocyte survival signalling pathway in the presence of Stat5
Previous research has shown that in conditions of myocardial I/R, reduced O2 availability leads to increased activity of hypoxia-inducible factor 1 (HIF-1), which coordinates adaptive responses through the transcriptional activation of hundreds of target genes, 23 in which VEGF contributes to angiogenesis. 24 We then detected the expression of HIF-1a
and VEGF in heart tissues, and results showed that RIPC-induced HIF-1a in the hearts of Stat5 fl/fl mice, whereas the effect was abolished in the absence of Stat5. Additionally, we found that the trend in VEGF expression corresponded with changes in HIF-1a ( Figure 7A-C) . These data suggest that Stat5 is critical for up-regulating HIF-1a and VEGF proteins during RIPC. Furthermore, we measured the level of IL10, reported to be an important cytokine in the cardioprotection of RIPC through activating PI3K and AKT, as one of the targets of HIF-1a signalling.
17,25
Our results showed that the protein levels of IL10 (P < 0.05), p-PI3K (P < 0.05), and p-AKT (P < 0.05) were elevated by RIPC in the presence of Stat5. In contrast, the RIPC stimulus had no effect on IL10 and PI3K phosphorylation in the hearts of Stat5-cKO mice, further indicating a critical role of Stat5 in the survival signaling induced by the RIPC stimulus. Unexpectedly, a decreased level of p-AKT was detected in the Stat5-cKO mice with RIPC stimulation compared to the Stat5-cKO mice undergoing sham surgery. Considering that in this study we detected the total and phosphorylated proteins in separate gels, we then normalized p-AKT with GAPDH only, and found that the ratio of p-AKT to GAPDH in these two groups reached the same level (see Supplementary material online, Figure S2 ).
Discussion
Myocardial I/R results in high morbidity and mortality. RIPC, induced by several brief cycles of I/R from a distance, confers multi-organ protection against IR injury. In this study, we generated cardiomyocyte-specific Stat5-cKO mice for the first time to explore the role of Stat5 in RIPC. Our results demonstrated that in the absence of 65% ( Figure 1C and D) of STAT5 at the protein level, the cardiomyocyte-restricted Stat5-cKO maintains a normal cardiac phenotype but abrogates the protective effects of RIPC against I/ R. This incomplete loss of STAT5 is likely due to the non-myocyte cell populations in the heart, including the endocardium and cardiac fibroblasts, which do not express Tnnt2. 30 Unexpectedly, p-STAT5 was detected in the heart of Stat5-cKO mice to an increased extent compared with the Stat5 fl/fl þI/R group. This may be the result of the complete activation of the remaining STAT5 protein when the heart was exposed to I/R stimulation. These observations need to be addressed mechanistically in our future studies. However, when we used GAPDH as baseline to normalize p-STAT5, the result indicated that there is no significant difference between the Stat5 fl/fl þI/R group and the Stat5-cKO þ I/R group (see Supplementary material online, Figure S1A-C) . This reminds us that the decreased total STAT5 protein level may falsely elevated the ratio of p-STAT5/STAT5.
Stat3, mainly present in the matrix of subsarcolemmal and interfibrillar cardiomyocyte mitochondria, and highly homogeneous with Stat5, reportedly contributes to RIPC-induced cardioprotection by stimulation of respiration and inhibition of MPTP opening. 11, 20, 31 Additionally, it has been shown that the increased activation of STAT5 does not provide functional compensation for the genetic deletion of cardiomyocyte Stat3. 32 In our study, we observed that in the hearts lacking STAT5, STAT3 activation in the cardiomyocytes varied following I/R challenge but was not further increased by RIPC. More importantly, increased activation of STAT3 did not offer protection against I/R-induced cardiac dysfunction, nor did it improve cardiac performance following RIPC. which were localized within non-infarcted risk area. Specific DNA fragments in apoptotic cell nuclei were stained in green using TUNEL on the heart biopsy slides, and cardiomyocytes were marked with a-actinin with red fluorescence, the nuclei showed a blue fluorescence stained with DAPI (bar length =100 lm). These results demonstrate that STAT5 activation is essential for RIPCinduced cardioprotection; and that when Stat5 is knocked out, Stat3 becomes enriched and activates in times of I/R, but the activation of STAT3 is insufficient to rescue the function of Stat5 in this specific RIPC model ( Figure 5C and D) .
Recent studies and literatures have identified different forms of cardiomyocyte death during I/R that contribute in determining the final IS. These forms include necrosis (a form of cell death caused by cell injury in living tissues), apoptosis (a process of programmed cell death and characterized by deoxyribonucleic acid strand breaks), autophagy (a regulated process of lysosomal degradation and recycling of proteins, including mitochondrial proteins), and necroptosis (combined features of necrosis and apoptosis). 33 Necrosis and apoptosis are important forms of cardiomyocyte death that occur in the initial stages of reperfusion injury. 34 Although the role of apoptosis is rather contentious in myocardial infarction, 35 it is still widely accepted that inhibition of apoptosis can attenuate myocardial damage, decrease cardiomyocyte removal, and improve ventricular contractile function that has been impaired by I/R. 34, 36, 37 The results of TUNEL-staining ( Figure 4 ) in our study indicates that protective effect of Stat5 in RIPC following I/R challenge may involve a rebalancing of pro-and anti-apoptotic factors. The activation of Stat5 contributes to the immediate-early induction of BclxL, possibly through direct-binding to the promoter of the Bcl-xL gene and up-regulating its expression. 38 The anti-apoptotic Bcl2 family proteins, including Bcl-2 and Bcl-xL, and the pro-apoptotic proteins, including Cyt c and Caspase-3, maintain the balance of apoptosis.
39-43
The release of Cyt c from the mitochondria leads to the activation of the executioner Caspase-3, and this event is inhibited by Bcl-2. 41, 42 Our study demonstrates that RIPC significantly increases the anti-apoptotic levels of Bcl-2 and Bcl-xL, all the while decreasing the release of proapoptotic molecules Cyt c, thus suppressing the activation of cleaved Caspase-3 from the I/R heart in Stat5 fl/fl mice. In contrast, neither of these two groups of proteins changed in the hearts of Stat5-cKO mice exposed to RIPC. Furthermore, both of these apoptotic proteins do not appear to be different between the Stat5 fl/fl þI/R and the Stat5-cKO þ I/R groups. These results indicate that Stat5 participates in the RIPC-mediated cardioprotection via an anti-apoptotic mechanism.
HIF-1a, a subunit of HIF-1, increases under hypoxia and induces hypoxia-mediated gene expression. 44 Vascular endothelial growth factor (VEGF), the downstream target gene of HIF-1a, is important in I/R because it regulates collateral vessel development and promotes angiogenesis. 18, 45 Studies have shown that in response to hypoxia, followed by reoxygenation stimuli, gene transcription of IL10 occurs in a HIF-1a-dependent manner. This leads to activation of the PI3K/AKT-mediated survival signals, resulting in an increase in cardiomyocyte survival following RIPC treatment. 17, 25, 46 Our results also demonstrate that RIPC signif- Stat5-dependent cardioprotection in late remote ischaemia preconditioning levels and activates the PI3K/AKT pathway. 17, 25 The PI3K/AKT pathway is a crucial downstream effector of JAK2/STAT5 signalling, which is supported by the observation that a conditional knockout of AKT1 truncates the survival of mammary epithelial cells that express hyperactive STAT5. 47 The engaging of JAK2/STAT5 signaling in a crosstalk with the PI3K/AKT cascade is further substantiated by experimental evidence that shows that the proliferation of JAK2-deficient cells can be restored through expression of myristolated AKT1 or constitutively nuclear Cyclin D1 that cannot be phosphorylated by GSK-3b. 48 However, the expression of mRNAs of PI3K and AKT varies significantly between organs, or even among different physiological states of the same tissue. We observed in our study a marked decrease in p-AKT protein in the hearts of Stat5-cKO mice that were subjected to RIPC, compared with mice that were subjected to I/R only. This observation suggests that AKT is a crucial downstream effector of STAT5 signaling, which may be instituted by RIPC, though this study did not provide sufficient evidence for it. In our study, we explore the mechanisms of RIPC-induced late protection against myocardial IR injury in mice. However, the mechanisms through which a series of reactions in skeletal muscles subjected to RIPC regulates changes seen in the heart are still not very clear. One report suggests that RIPC mediates late cardioprotection by increasing expression of IL-10 in the skeletal muscle, followed by a release of IL-10 into the circulation, and activation of protective signalling pathways in the heart. 25 Further investigation into additional mechanisms need to be explored in the future.
Conclusions
Our study uses Stat5-cKO mice to indicate that late RIPC protects against myocardial I/R injury, and its mechanism is Stat5-dependent. We also show that Stat5 plays a key role in RIPC-mediated late cardioprotection through anti-apoptotic signaling and the PI3K/AKT survival pathway (Figure 8 ). 
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